Loading...

CTNM CONTINEUM THERAPEUTICS INC Management Changes 8-K Filing

CNTN

CTNM

CONTINEUM THERAPEUTICS INC

(CTNM)

2026 8-K

New Funding Agreement

New Equity Plan

Clinical Trial Update

Clinical Trial Update

Q3 Financial Results

Clinical Trial Results

Financial Statements

Management Changes

Board Appointment

Financial Results

Financial Results

External Links:

Contineum Therapeutics, Inc. established a new 2026 Employment Inducement Equity Incentive Plan on January 23, 2026, reserving 750,000 shares for employee grants without stockholder approval. This plan resembles the previous 2024 Equity Incentive Plan but excludes incentive stock options.

AI Assistant

CONTINEUM THERAPEUTICS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.